Precision BioLogic Acquires George King Bio-Medical

October 16, 2025

Precision BioLogic Inc., a Halifax-based developer of hemostasis diagnostic products, has acquired George King Bio-Medical, Inc., a provider of fresh frozen human plasmas and hemostasis diagnostic reagents based in Overland Park, Kansas. The acquisition is intended to combine product portfolios and continue serving the bleeding disorders community while exploring new opportunities under the Precision BioLogic umbrella.

Buyers
Precision BioLogic Inc.
Targets
George King Bio-Medical, Inc.
Industry
Medical Devices
Location
Kansas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.